» Articles » PMID: 10617204

Transmissible and Genetic Prion Diseases Share a Common Pathway of Neurodegeneration

Overview
Journal Nature
Specialty Science
Date 2000 Jan 5
PMID 10617204
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Prion diseases can be infectious, sporadic and genetic. The infectious forms of these diseases, including bovine spongiform encephalopathy and Creutzfeldt-Jakob disease, are usually characterized by the accumulation in the brain of the transmissible pathogen, an abnormally folded isoform of the prion protein (PrP) termed PrPSc. However, certain inherited PrP mutations appear to cause neurodegeneration in the absence of PrPSc, working instead by favoured synthesis of CtmPrP, a transmembrane form of PrP. The relationship between the neurodegeneration seen in transmissible prion diseases involving PrPSc and that associated with ctmPrP has remained unclear. Here we find that the effectiveness of accumulated PrPSc in causing neurodegenerative disease depends upon the predilection of host-encoded PrP to be made in the ctmPrP form. Furthermore, the time course of PrPSc accumulation in transmissible prion disease is followed closely by increased generation of CtmPrP. Thus, the accumulation of PrPSc appears to modulate in trans the events involved in generating or metabolising CtmPrP. Together, these data suggest that the events of CtmPrP-mediated neurodegeneration may represent a common step in the pathogenesis of genetic and infectious prion diseases.

Citing Articles

Protective role of cytosolic prion protein against virus infection in prion-infected cells.

Hara H, Chida J, Batchuluun B, Takahashi E, Kido H, Sakaguchi S J Virol. 2024; 98(9):e0126224.

PMID: 39194237 PMC: 11406989. DOI: 10.1128/jvi.01262-24.


(Dys)functional insights into nucleic acids and RNA-binding proteins modulation of the prion protein and α-synuclein phase separation.

Cordeiro Y, Freire M, Wiecikowski A, Juliani do Amaral M Biophys Rev. 2023; 15(4):577-589.

PMID: 37681103 PMC: 10480379. DOI: 10.1007/s12551-023-01067-4.


Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease.

Vallabh S, Zou D, Pitstick R, OMoore J, Peters J, Silvius D J Virol. 2023; 97(2):e0167222.

PMID: 36651748 PMC: 9973041. DOI: 10.1128/jvi.01672-22.


Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition.

Subedi S, Sasidharan S, Nag N, Saudagar P, Tripathi T Molecules. 2022; 27(6).

PMID: 35335141 PMC: 8955620. DOI: 10.3390/molecules27061776.


Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis.

Alpert E, Akhavan A, Gruzman A, Hansen W, Lehrer-Graiwer J, Hall S Biosci Rep. 2021; 41(10).

PMID: 34677582 PMC: 8536833. DOI: 10.1042/BSR20211646.